Full Press Release Details
TARRYTOWN, N.Y.,Oct. 21, 2016/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast its presentation at the 25thAnnual Credit Suisse Healthcare Conference at10:00 a.m. ETonTuesday, November 8, 2016.
The session may be accessed through the Company's web site,www.regeneron.com, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.Regeneron (NASDAQ:REGN) is a leading science-based biopharmaceutical company based inTarrytown, New Yorkthat discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition, and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, asthma, atopic dermatitis, pain, oncology, and infectious diseases. For additional information about the company, please visitwww.regeneron.comor follow @Regeneron on Twitter.
| Contact Information: | |
| Investor Relations | Corporate Communications |
| Manisha Narasimhan, Ph.D. | Hala Mirza |
| 914.847.5126 | 914.847.3422 |
| [email protected] | [email protected] |